JST Programs/Projects
JST Headquarters Website
  What's New

JST president Dr. Hamaguchi joined the Delphi Economic Forum VI as a panelist of the session "The Frontiers of Technological Innovation: Re-Shaping Our World" that was co-hosted by the Global Federation of Competitiveness Councils (GFCC).
He shared his vision that the new generation - the young people who will actually be alive and active by 2050 - should be involved in building the future of economies and societies. Current stakeholders must be sure they meet the needs of future stakeholders.
The session was moderated by Mr. Chad Evance, Executive Vice President, Council on Competitiveness. The panelists were:

Dr. Michinari Hamaguchi, President, JST
Dr. Maher Hakim, Chief Advisor, Innovation and Enterprise, Qatar Research, Development and Innovation Council
Dr. Eric Smitt, Director, Advanced Technology Center, Lockheed Martin Corporation

Youtube link is available now.
https://www.youtube.com/watch?v=r4r9_dPJjmY

Dr. Shimada, director of JST's Washington, D.C. Office gave a presentation at a Monthly Call of the Global Federation of Competitiveness Councils (GFCC).
He shared with GFCC members the information on how JST is envisioning the future for the 6th Science, Technology and Innovation Basic Plan and beyond, mentioning a) convergent activities for achieving Moonshot goals, overcoming COVID-19 and tackling local issues, and b) inclusion & co-creation beyond business sectors, generations, and national borders.

Youtube link is available now.
https://www.youtube.com/watch?v=UgQlWA1Pv-M&list=PLm313Mhid_AtTSo6QnNcz-CREixhTx1K6&index=15

A workshop on thermal transport, materials informatics and quantum computing, co-sponsored by JST and NSF, was held online for four consecutive days from March 22-25. It was an opportunity to add momentum to academic conversations among the thermal transport communities and the greater materials informatics communities, helping to promote international collaboration initiatives.

Dr. Shimada, director of JST's Washington, D.C. Office, delivered opening remarks on behalf of JST to emphasize the importance of positive attitudes and passion when attempting collaboration between Japan and the US. He highlighted the MOC effective from October 7, 2018 as JST-NSF's organizational cooperative framework. Ms. Anne Emig, Cluster Lead, Office of International Science and Engineering represented NSF, and talked about the important steps necessary to strengthen JST-NSF collaborative efforts.

Workshop website:
https://aithermworkshop.nd.edu/

A JST-Stanford Symposium titled "Practical Innovations against COVID-19" was co-hosted by JST and Stanford University. JST president Dr. Hamaguchi opened with remarks noting the importance of JST's COVID-19 response 'Plan B'*. Chair of Stanford University School of Medicine's Anesthesia Department, Dr. Pearl, also provided a welcome message to emphasize the importance of potential collaboration between JST and Stanford University.

The symposium featured 3 keynote speakers:

- Hiroshi Amano, Professor, Nagoya University, 2014 Nobel Laureate in Physics
- Yasuhiro Tsukamoto, President, Kyoto Prefectural University
- Michael Snyder, Professor, Stanford University School of Medicine

These keynote speakers brought a variety of perspectives. Prof. Amano explained about the recent development of deep ultraviolet light-emitting diodes (DUV LEDs) and the air/water purification systems in which DUV LEDs are used to decontaminate surfaces that have come into contact with COVID-19. Dr. Tsukamoto introduced several applications of the ostrich antibody, e.g. an antiviral non-woven fabric facemask using the antibody. Prof. Snyder demonstrated how wearables data can be used for early, presymptomatic detection of COVID-19. For the following panel discussion, topics included our common challenges, ways to help each other, and win-win collaborations between Stanford and JST.

*Plan B is a multidisciplinary approach to create a society in which we can move, meet, gather and do business freely under COVID-19 conditions, alongside Plan A (trials of vaccines and drugs).